No Result
View All Result
SUBMIT YOUR ARTICLES
  • Login
Friday, October 24, 2025
TheAdviserMagazine.com
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
No Result
View All Result
TheAdviserMagazine.com
No Result
View All Result
Home Market Research Markets

Earnings Preview: What to expect from Procter & Gamble’s Q1 FY26 report

by TheAdviserMagazine
3 days ago
in Markets
Reading Time: 3 mins read
A A
Earnings Preview: What to expect from Procter & Gamble’s Q1 FY26 report
Share on FacebookShare on TwitterShare on LInkedIn


The Procter & Gamble Company (NYSE: PG) is set to report its first-quarter results on Friday, with Wall Street analysts forecasting a modest YoY increase in sales. The company is leaning on productivity gains and strategic pricing to ease the impact of economic uncertainties on the business, but has warned of significant tariff headwinds in the current fiscal year. P&G is the largest consumer goods company, consistently dominating in categories like Fabric & Homecare and Grooming.

Estimates

P&G will publish its first-quarter 2026 financial results on Friday, October 24, at 7:00 am ET. It is estimated that core earnings declined modestly to $1.90 per share in Q1 from $1.93 per share in the year-ago quarter. The consensus sales estimate for the September quarter is $22.17 billion, which represents a 2% year-over-year increase. In Q4, both sales and profit beat analysts’ expectations, after missing in the prior quarter.

Based on the last closing price, P&G shares have slid about 14% since hitting an all-time high in December last year. After entering 2025 on a positive note, PG lost momentum and has experienced high volatility, maintaining a downtrend. The value has dropped about 10% since the beginning of the year.

Sales Rise

In the fourth quarter of FY25, Procter & Gamble’s net sales were $20.9 billion, up 2% versus Q4 2024. Organic sales increased 2%. Core earnings, excluding special items, rose 6% annually to $1.48 per share in the fourth quarter. Unadjusted net income attributable to shareholders was $3.6 billion, up 15% from the prior-year period.

From Procter & Gamble’s Q4 2024 Earnings Call:

“The innovation plans across the businesses are broad and strong as each category team works to increase their margin of superiority and consumer delight. Superior innovations that are driven by deep consumer insights communicated to consumers with more effective and efficient marketing programs, executed in stores and online in conjunction with retailer strategies to grow categories and our brands and priced to deliver superior value across each price tier where we compete.”

Outlook

The P&G leadership said it expects sales to grow 1-5% in fiscal 2026, and core earnings per share to be flat to up 4%. The guidance for full-year reported earnings per share growth is 3-9%. The company sees $1 billion in additional costs related to new import tariffs, and targets a mid-single-digit increase in prices of products affected by tariffs, which of about 25% of all items. Earlier this year, the company announced an organizational restructuring, with a focus on ramping portfolio and streamlining the supply chain. The revamp will include the reduction of around 7,000 non-manufacturing roles.

On Tuesday, Procter & Gamble shares opened at $151.96 and traded mostly lower during the session. The average stock price for the last 52 weeks is $163.08.



Source link

Tags: earningsExpectFY26gamblesPreviewProcterReport
ShareTweetShare
Previous Post

Smoke-free momentum drives another strong quarter for Philip Morris (PM) in Q3 2025

Next Post

Salesforce revamps its ‘Agentforce’ offerings to try to pull customers across the gap between AI capabilities and AI adoption

Related Posts

edit post
China strikes conciliatory tone ahead of expected Trump-Xi meeting

China strikes conciliatory tone ahead of expected Trump-Xi meeting

by TheAdviserMagazine
October 24, 2025
0

China's Minister of Commerce Wang Wentao spoke alongside other senior officials at a press conference on Friday, Oct. 24, 2025.Picture...

edit post
How Some Retirees Are Finding Happiness Again After Age 60

How Some Retirees Are Finding Happiness Again After Age 60

by TheAdviserMagazine
October 23, 2025
0

JLco Julia Amaral / Shutterstock.comIf you are an unhappy senior, there is hope. About 1 in 4 adults who are...

edit post
INTC Earnings: Intel swings to profit in Q3 FY25; revenue up 3%

INTC Earnings: Intel swings to profit in Q3 FY25; revenue up 3%

by TheAdviserMagazine
October 23, 2025
0

Semiconductor giant Intel Corporation (NASDAQ: INTC) reported a profit for the third quarter of fiscal 2025, compared to a loss in...

edit post
An Age-Old Fear Grows More Common: ‘I’m Going to Die Alone’

An Age-Old Fear Grows More Common: ‘I’m Going to Die Alone’

by TheAdviserMagazine
October 23, 2025
0

imtmphoto / Shutterstock.comThis summer, at dinner with her best friend, Jacki Barden raised an uncomfortable topic: the possibility that she...

edit post
5 Ways Medicare Advantage Plans Are About to Change

5 Ways Medicare Advantage Plans Are About to Change

by TheAdviserMagazine
October 23, 2025
0

Lordn / Shutterstock.comIf you thought last year’s Medicare open enrollment was tough, brace yourself. The 2026 enrollment period brings another...

edit post
‘Cash, precious metals, crypto’ is new norm for peak stock market risk

‘Cash, precious metals, crypto’ is new norm for peak stock market risk

by TheAdviserMagazine
October 23, 2025
0

With a handful of mega-cap tech and AI stocks at the top of the S&P 500 Index dominating the U.S....

Next Post
edit post
Salesforce revamps its ‘Agentforce’ offerings to try to pull customers across the gap between AI capabilities and AI adoption

Salesforce revamps its 'Agentforce' offerings to try to pull customers across the gap between AI capabilities and AI adoption

edit post
New Trezor Safe 7 Boasts Quantum-Resistant Design and Dual Secure Elements

New Trezor Safe 7 Boasts Quantum-Resistant Design and Dual Secure Elements

  • Trending
  • Comments
  • Latest
edit post
77-year-old popular furniture retailer closes store locations

77-year-old popular furniture retailer closes store locations

October 18, 2025
edit post
Pennsylvania House of Representatives Rejects Update to Child Custody Laws

Pennsylvania House of Representatives Rejects Update to Child Custody Laws

October 7, 2025
edit post
What to Do When a Loved One Dies in North Carolina

What to Do When a Loved One Dies in North Carolina

October 8, 2025
edit post
Probate vs. Non-Probate Assets: What’s the Difference?

Probate vs. Non-Probate Assets: What’s the Difference?

October 17, 2025
edit post
California Attorney Pleads Guilty For Role In 2M Ponzi Scheme

California Attorney Pleads Guilty For Role In $912M Ponzi Scheme

October 15, 2025
edit post
Baby Boomers Are Flocking to This Florida Town — but Not for the Weather

Baby Boomers Are Flocking to This Florida Town — but Not for the Weather

October 9, 2025
edit post
7 Overlooked Pairings of VA + Medicare That Slash Out-of-Pocket Costs

7 Overlooked Pairings of VA + Medicare That Slash Out-of-Pocket Costs

0
edit post
Amazon LEGO Set Deals: LEGO Sunflowers Set only .99, plus more!

Amazon LEGO Set Deals: LEGO Sunflowers Set only $7.99, plus more!

0
edit post
The 9 Largest NYC Tech Startup Funding Rounds of September 2025 – AlleyWatch

The 9 Largest NYC Tech Startup Funding Rounds of September 2025 – AlleyWatch

0
edit post
Comprehensive Sodium-Ion Battery Market Analysis: Demand Forecast

Comprehensive Sodium-Ion Battery Market Analysis: Demand Forecast

0
edit post
FINRA investigates IPOs of small foreign firm

FINRA investigates IPOs of small foreign firm

0
edit post
Is It Too Late to Buy After the 40% YTD Surge?

Is It Too Late to Buy After the 40% YTD Surge?

0
edit post
Paytm and Vedanta emerge as top buys amid sectoral rotation and profit booking: CA Rudramurthy BV

Paytm and Vedanta emerge as top buys amid sectoral rotation and profit booking: CA Rudramurthy BV

October 24, 2025
edit post
Comprehensive Sodium-Ion Battery Market Analysis: Demand Forecast

Comprehensive Sodium-Ion Battery Market Analysis: Demand Forecast

October 24, 2025
edit post
Alnylam Pharmaceuticals – ALNY: Volkskrankheit Bluthochdruck im Visier!

Alnylam Pharmaceuticals – ALNY: Volkskrankheit Bluthochdruck im Visier!

October 24, 2025
edit post
China strikes conciliatory tone ahead of expected Trump-Xi meeting

China strikes conciliatory tone ahead of expected Trump-Xi meeting

October 24, 2025
edit post
Hyperliquid Price Breaks Key Resistance as B Fundraising and IPO Plans Gain Traction

Hyperliquid Price Breaks Key Resistance as $1B Fundraising and IPO Plans Gain Traction

October 24, 2025
edit post
Tomatoes Rs 600 per kg, capsicum Rs 300: Pakistanis are paying a heavy price after conflict with Afghanistan

Tomatoes Rs 600 per kg, capsicum Rs 300: Pakistanis are paying a heavy price after conflict with Afghanistan

October 24, 2025
The Adviser Magazine

The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.

CATEGORIES

  • 401k Plans
  • Business
  • College
  • Cryptocurrency
  • Economy
  • Estate Plans
  • Financial Planning
  • Investing
  • IRS & Taxes
  • Legal
  • Market Analysis
  • Markets
  • Medicare
  • Money
  • Personal Finance
  • Social Security
  • Startups
  • Stock Market
  • Trading

LATEST UPDATES

  • Paytm and Vedanta emerge as top buys amid sectoral rotation and profit booking: CA Rudramurthy BV
  • Comprehensive Sodium-Ion Battery Market Analysis: Demand Forecast
  • Alnylam Pharmaceuticals – ALNY: Volkskrankheit Bluthochdruck im Visier!
  • Our Great Privacy Policy
  • Terms of Use, Legal Notices & Disclosures
  • Contact us
  • About Us

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.